Nykode Therapeutics ASA

Nykode Therapeutics ASA financial statements

Nykode Therapeutics ASA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 12.24MEODHD
Cash and equivalentsUSD 60.29MEODHD

Nykode Therapeutics ASA financials on 6ix · Nykode Therapeutics ASA on 6ix